Jessica M. Monteiro
FDA investigator
Appears on 2 documents from 2018 to 2023, mostly at sites in New Jersey. Most often cites written procedures; deviations (21 CFR 211.100).
- 2
- Documents on file
- 4.5
- Observations per 483
- 2018
- First seen
- 2023
- Most recent
What they cite most
From 9 observations- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.142Warehousing procedures1
- 21 CFR 211.150Distribution procedures1
- 21 CFR 211.160General requirements1
- 21 CFR 211.198Complaint files1
- 21 CFR 211.204Returned drug products1
Activity by year
2018: 1, 2023: 1
Where
New Jersey 2
Often inspects with
Is Jessica M. Monteiro coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2023-07-14 | 483 Aspire Pharmaceuticals Inc.Jul 14, 2023 · Somerset, New Jersey | Somerset, New Jersey | 1 | |
| 2018-01-10 | 483 Flawless Beauty LLCJan 10, 2018 · Ocean, New Jersey | Ocean, New Jersey | 8 |
About this profile
What does Jessica M. Monteiro inspect?
Jessica M. Monteiro appears on 2 documents on file covering 2 sites, mostly in New Jersey.
What do they cite most often?
21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.142 and 21 CFR 211.150.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Jessica M. Monteiro is dated Jul 14, 2023.